Comparison of salmeterol with placebo in mild asthma: Effect on peripheral blood phagocyte function and cytokine levels

International Archives of Allergy and Immunology

Volumn 105, Issue 2, 1994, Pages 181-184

  Ramage, Lynn ^a   Cree, Ian A ^a   Paul Dhillon, D ^b  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b King's Cross Hospital   (United Kingdom)

Author keywords

Asthma; Chemiluminescence; Cytokine; Phagocyte; Salmeterol; Adrenoceptor agonist

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 6; SALMETEROL;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; BRONCHODILATING ACTIVITY; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MALE; PHAGOCYTE; PHAGOCYTOSIS; PRIORITY JOURNAL; SPIROMETRY;

ADULT; ALBUTEROL; ASTHMA; CHEMILUMINESCENT MEASUREMENTS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INTERLEUKINS; MALE; PHAGOCYTES; PLACEBOS; RECEPTORS, INTERLEUKIN-2;

EID: 0027991787     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000236822     Document Type: Article

References (24)

1. Editorial: Beta-agonists in asthma: Relief, prevention, morbidity. Lancet 1990; 336: 1411-1412.
2. Church MK, Hiroi J: Inhibition of igE dependent histamine release from human dispersed lung mast cels by anti-allergic drugs and salbutainol. Br J Pharmacol 1987; 90: 421-429.
3. Ratnage L, Cree IA, Blair AL, Dhillon DP: The effect of beta-agonists on polymorphonuclear cell (PMNL) function in vitro; in Stanley PE, Kricka LJ (eds): Bioluminescence and Chem-iluminescence. Current Status. Chichester, Wiley, 1991, pp 309-312.
4. Ramage L, Cree IA, Blair AL, Dhillon DP: Effect of salmeterol on polymorphonuclear leukocyte (PMNL) chcmilumincscence in vitro. J Biolumin Chemilumin 1993; 8: 247-252.
5. Johnson M: The pharmacology of salmeterol. Lung 1990; 168 (suppl): 115-119.
6. Baker AJ, Fuller RW: Anti-inflammatory effect of salmeterol on human alveolar macrophages. Am Rev Respir Dis 1990; 141: A394.
7. Twentyman OP, Finnerty JP, Harris A, Palmer J, Holgate ST: Protection against allergen-induced asthma by salmeterol. Lancet 1990; 336: 1338-1342.
8. Carroll MP, Durham SR, Walsh G, Kay AB: Activation of neutrophils and monocytes after allergen- and histamine-induced bronchocon-striction. J Allergy Clin Immunol 1985; 75: 290-296.
9. Cluzel P, Damon M, Chanez P, Bousquet J, Crastes de Paulet A, Michel FB, Godard Ph: Enhanced alveolar cell luminol-dependent chem-iluminescence in asthma. J Allergy Clin Immunol 1987; 80: 195-201.
10. Djukanovich R, Roche WR, Wilson JW, Beasley CRW, Twentyman OP, Howarth PH, Holgate ST: Mucosal inflammation in asthma. Am Rev Respir Dis 1990; 142: 434-457.
11. Ramage L, Ingram C, Cree IA, Dhillon DP: Chronic dosing with inhaled salmeterol in exercise-induced asthma. Respir Med, in press.
12. Cotes JE: Lung Function: Assessment and Application in Medicine, ed 3. London, Blackwell Scientific, 1975.
13. Anderson D, English BR: Single-step separation of red blood cells, granulocytes and mononuclear leukocytes on discontinuous density gradients of Ficoll-Hypaque. J Immunol Methods 1974; 5: 249-252.
14. Blair AL, Cree IA, Beck JS, Hastings MJG: Measurement of phagocyte chemiluminescence in a microtitre plate foπnat. J Immunol Methods 1988; 112: 163-168.
15. Cree IA: Longitudinal studies of phagocyte chemiluminescence in patients with lung disease; in Szalay A, Kricka LJ, Stanley PE (eds): Chemiluminescence and Bioluminescence. Status Report. Chichester, Wiley, 1993, pp 451-455.
16. Kanazawa H, Kurihara N, Hirata K, Takeda T: The role of free radicals in airway obstruction in asthmatic patients. Chest 1991; 100: 1319-1322.
17. Meltzer S, Goldberg B, Lad P, Easton J: Superoxide generation and its modulation by adenosine in the neutrophils of subjects with asthma. J Allergy Clin Immunol 1989; 83: 960-966.
18. Kelly CA, Ward C, Stenton SC, Bird G, Hendrick DJ, Walters EH: Number and activity of inflammatory cells in bronchoalveolar lavage fluid in asthma and their relation to airways responsiveness. Thoras 1988; 43: 684-692.
19. Aas K: Heterogenicity of bronchial asthma. Allergy 1981; 3: 3-14.
20. Damon M, Cluzel P, Chanez P, Godard Ph: Phagocytosis induction of chemiluminescence and chemoattractant increased superoxide anion release from activated human alveolar macrophages in asthma. J Biolumin Chemilumin 1989; 4: 279-286.
21. Brown PH, Crompton GK, Greening AP: Proin-flammatory cytokines in acute asthma. Lancet 1991; 338: 590-593.
22. Corrigan CJ, Kay AB: T cells and eosinophils in the pathogenesis of asthma. Immunol Today 1992; 13: 501-507.
23. Lassalle P, Sergant M, Delneste Y, Gosset P, Wallcart B, Zandecki M, Capron A, Joseph M, Tonnsll AB: Levels of soluble IL-2 receptor in plasma from asthmatics. Correlations with blood eosinophilia, lung function, and corticosteroid therapy. Clin Exp Immunol 1992; 87: 266-271.
24. Lai CK, Chan CH, Leung JC, Lai KN: Serum concentrations of soluble interleukin 2 receptors in asthma. Correlation with disease activity. Chest 1993; 103: 782-786.